Skip to content

System Accuracy and Performance Evaluation by the User of BGM LS-9

Evaluation of the Blood Glucose Monitoring System LS-9 of Leison Biotech Co., Ltd. in Accordance With DIN EN ISO 15197:2015

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07353125
Enrollment
219
Registered
2026-01-20
Start date
2025-07-21
Completion date
2025-09-22
Last updated
2026-01-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Keywords

System Accuracy, Performance Evaluation by the User, DIN EN ISO 15197

Brief summary

This study assesses the system accuracy and performance evaluation by the user of a blood glucose monitoring system pursuant to ISO 15197

Interventions

DIAGNOSTIC_TESTGlucometer Test

blood glucose measurement using finger tip capillary blood using BGM and reference method

Sponsors

Institut fur Diabetes Karlsburg GmbH
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or female patients with hypo-, eu- or hyperglycaemia * The written informed consent had to be signed * The volunteers must be older than 18 years * The volunteers have legal capacity and are able to understand meaning, nature and possible consequences of the procedures involved

Exclusion criteria

* Pregnancy or lactation * Acute or chronic diseases with the risk of aggravation by the measure * A current constitution that does not allow participating in the study * Participation in another study or activity with the blood glucose measuring system evaluated in the present study * Application of substances listed in Appendix A of DIN EN ISO 15197:2015

Design outcomes

Primary

MeasureTime frameDescription
Analysis of system accuracy based on DIN EN ISO 15197Day 1Assessment of the analytical measurement performance of the blood glucose monitor in accordance with DIN EN ISO 15197, section 6.3

Countries

Germany

Contacts

STUDY_DIRECTOREckhard Salzsieder, PhD

Institut fur Diabetes Karlsburg GmbH

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026